By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 112.82 |
Change Today | $ 0.11 |
% Change | 0.10 % |
52 Week High | $121.40 |
52 Week Low | $78.72 |
Volume | 2,247,475 |
Shares Issued | 1,246.00m |
Market Cap | $140,574m |
RiskGrade | 120 |
Strong Buy | 9 |
Buy | 12 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
14:25 | 100 @ $112.82 |
14:24 | 100 @ $112.83 |
14:24 | 427 @ $112.82 |
14:24 | 100 @ $112.82 |
14:24 | 100 @ $112.82 |
You are here: research